Pandion Therapeutics Inc (PAND) Stock News

USA - NASDAQ:PAND -

60.05

+0.13 (+0.22%)

Last: 3/31/2021, 8:12:53 PM

60.05

0 (0%)

After Hours: 3/31/2021, 8:12:53 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

PAND Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: Bloomberg - Mentions: MRK

Ex-FBI Trainee Gets 15 Months for Trading on Girlfriend’s Info

5 years ago - By: Benzinga

News Image

Analyzing The Price Action In Pandion Therapeutics Stock Today

5 years ago - By: Benzinga - Mentions: ITOS MOR KMPH NRIX ...

The Daily Biotech Pulse: KemPharm ADHD Drug Gets The Nod, MediciNova Shelves Vaccine Study

5 years ago - By: Kahn Swick & Foti, LLC

PANDION THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Pandion Therapeutics, Inc. - PAND

5 years ago - By: Monteverde & Associates PC

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Pandion Therapeutics, Inc. - PAND

5 years ago - By: StockMarket.com - Mentions: VRTX MRNA PFE MRK ...

Are These The Top Biotech Stocks To Buy In March? 4 Names To Consider

5 years ago - By: The Motley Fool - Mentions: MRK

Why Pandion Therapeutics Stock Blasted Sky-High on Thursday

5 years ago - By: WeissLaw LLP - Mentions: MRK

SHAREHOLDER ALERT: WeissLaw LLP Investigates Pandion Therapeutics, Inc.

5 years ago - By: Halper Sadeh LLP

Pandion Therapeutics Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Pandion Therapeutics, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – PAND

5 years ago - By: InvestorPlace - Mentions: MRK

PAND Stock: Why Pandion Therapeutics Shares Have Skyrocketed Today

5 years ago - By: Investor's Business Daily - Mentions: MRK SNY

Pandion Therapeutics Surges To Record High On Merck's $1.85 Billion Buyout